<div id="readability-page-1">03:41 PM EST, 12/04/2025 (MT Newswires) -- Humana (HUM) is working with entrepreneur Mark Cuban on a potential pharmacy partnership through Cuban's Cost Plus Drugs venture, Bloomberg reported Thursday, citing comments made by Humana's chief executive officer Jim Rechtin at a Forbes healthcare conference.Cuban said the discussions include direct-to-employer programs aimed at bypassing traditional drug-supply-chain layers, the report said. Rechtin said the goal is to simplify how medications move from manufacturers to patients, the report said.Humana and Cost Plus Drugs did not immediately respond to MT Newswires' request for comment on the matter.Shares of Humana were down 2.14% in recent Thursday trading.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: 251.99, Change: -4.93, Percent Change: -1.92 MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

休曼纳

休曼纳正在与马克·库班的 Cost Plus Drugs 探索药房合作，旨在简化药物分发。讨论内容包括直接面向雇主的项目，以绕过传统的药物供应链层级。休曼纳的股价在消息公布后下跌了 2.14%

市场传闻：休曼纳正在考虑与马克·库班进行药房合作